| HOME >> BIOLOGY >> TECHNOLOGY |
HARBIN, China, July 6 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of cactus-based consumer products in China, announced today that it has retained the services of Hawk Associates for strategic investor relations. Information about China Kangtai will be available through the Hawk Associates website at: http://www.hawkassociates.com , featuring company updates, investor information and live financial feeds.
China Kangtai CEO Jinjiang Wang said, "We look forward to working with Hawk Associate, which has been providing comprehensive strategic IR services for 14 years in their roles as trusted advisors. We believe Hawk Associates is one of the premier investor relations firms that effectively helps companies successfully communicate their stories to the investment community. The branding and investor relations expertise that Hawk provides will be essential in assisting management in showcasing the true value of our company."
Hawk Associates CEO Frank Hawkins said, "As the dominant producer with 60% market share of China's edible cactus production, China Kangtai is a major beneficiary of growing Chinese demand for health and wellness products. In China, cactus products are traditionally used for treatment for health issues such as diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity and skin disorders. This is a unique company in an unsaturated industry. With the company's recent acquisition in March, Kangtai is seeking to increase its production capabilities in an effort to enhance its overall growth. We are thrilled to be able to help Kangtai tell its story to the investment community to strengthen its long-term valuation."
About China Kangtai Cactus Biotech, Inc.
China Kangtai C
'/>"/>
| SOURCE China Kangtai Cactus Biotech, Inc. Copyright©2009 PR Newswire. All rights reserved |